Immune Profiling

 

 

The Immune Profiling Conference brings together pharma and biotech, together with leading research institutes. They’re meeting to discuss how profiling of the immune system using high throughput technologies can aid therapeutic design and treatment strategies in infectious and non-infectious diseases including cancer. If you offer platforms or technologies that can help advance or predict the outcome of these companies pipeline, the event will allow you to showcase your services and technologies directly to them and generate awareness of what you do with key decision makers.

 

Who Attends

 

• Pharma
• Biotech
• Research Institutions
• Universities

 

Job Titles

 

• Head of Immunology
• Head of Translational & Immuno- Oncology
• Director Predictive Medicine
• Head of Sequencing / Next gen sequencing
• Directors of Biomarker Discovery & Diagnostics
• Head of Bioinformatics
• Director of Research
• Head of Cancer Immunotherapy
• Translational Science & Adjuvants
• Head of Vaccines

Who Should Sponsor?

 

• DNA sequencing technologies
• Single cell technologies
• High-throughput sample processing and analysis
• Molecular diagnostics
• Molecular assays
• Equipment and device manufacturers
• Intellectual property advisors

 

Immune Profiling Conference, Tuesday 16 April 2019

Keynotes

Dr Stacey Wooden
Immune Profiling Conference
09:10

The immune setpoint: Baseline immune status predicts vaccine response

Richard Scheuermann
Immune Profiling Conference
10:10

Explainable artificial intelligence (XAI) to gain insights into vaccine action

10:40

Networking Coffee Break

Immune Profiling for Infectious Diseases

Ana Fernandez-Sesma
Immune Profiling Conference
11:40

Innate immune profiling for Dengue infection & vaccination

Dr Ana Fernandez-Sesma, Chair, Human Immunology Project Consortium & Professor, Icahn School Of Medicine, Mount Sinai
Ruth Montgomery
Immune Profiling Conference
12:10

Divergent immune responses to West Nile virus

Steven Kleinstein
Immune Profiling Conference
12:40

Systems-level profiling of the influenza vaccination response

13:10

Networking Lunch & Poster Session

Big Data

George Georgiou
Immune Profiling Conference
15:40

Analysis of the antibody repertoire elicited by viral infection and vaccination to aid the development of more efficient vaccines

16:10

Networking Coffee Break

Dr Will Singleterry
Immune Profiling Conference
16:40

Single cell functionality serves as a predictive biomarker for overall survival of pancreatic cancer patients treated with GVAX vaccine

Dr Ester Falconer
Immune Profiling Conference
17:10

Rapidly generated pandemic countermeasures by deep mining of natural immune repertoires

Dr Masahide Yano
Immune Profiling Conference
17:40

Interactive Discussion- Problem Solving: Application of next-generation sequencing to monitor disease progression

18:10

Chair’s Closing Remarks per co-lo and Close of Congress Day 2

18:15

Off-site Networking Drinks, Supported by Enesi Pharma

last published: 11/Apr/19 17:05

Immune Profiling Conference, Wednesday 17 April 2019

Immune Profiling Conference
09:00

Chair’s opening remarks

Precision Cancer Treatment

Professor Dean Felsher
Immune Profiling Conference
09:10

Targeting specific oncogenic pathways to restore the immune response against cancers

Rohan Fernandes
Immune Profiling Conference
09:40

Designing “nanoimmunotherapies” to modify the tumor microenvironment and potentiate robust systemic antitumor immune responses

Immune Profiling Conference

Biomarker Strategies & Patient Centricity

10:40

Networking Coffee Break

12:30

Networking Lunch & Poster Session

DAY 3 AFTERNOON PLENARY OF CONGRESS: RENAISSANCE BALLROOM

Paul Offit
13:40

New lessons from old controversies

  • What have we learnt from previous vaccines failures to drive new vaccines forward?
  • Why is there is low uptake on currently available vaccines? E.g. HPV & influenza
  • Examples and case studies from: Lyme & Rota – what does this mean for future vaccine innovation and R&D?
Dr Saad Omer
14:55

A framework for a comprehensive maternal immunization platform

  • Evidence for current immunization recommendations
  • Maternal vaccines in development
  • The need for evidence-based interventions at the practice, provider, and patient levels to ensure higher vaccination levels
Dr Timothy Cooke
16:00

Chair Closing Remarks and End of Congress

last published: 11/Apr/19 17:05

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071